AMGN vs CVS
By Alex · Tickerpine
Amgen Inc. vs CVS Health Corporation, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | AMGN | CVS |
|---|---|---|
| Price | $416.18 | $94.72 |
| Market cap | $225.15B | $121.14B |
| P/E ratio | 25.7 | 24.7 |
| ROE | 91.47% | 6.21% |
| Profit margin | 22.95% | 1.18% |
| Revenue growth | 9.50% | 7.10% |
| Dividend yield | 2.43% | 2.84% |
| Beta | 0.41 | 0.60 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
AMGN vs CVS in plain English
- AMGN is the bigger company — about 1.9× the market cap of CVS.
- CVS is cheaper on earnings (P/E 24.7 vs 25.7).
- AMGN earns a higher return on equity (91% vs 6%).
- AMGN is growing revenue faster (10% vs 7%).
- CVS has the higher dividend yield (2.84% vs 2.43%).
How would $1,000 have done in each?
AMGN return calculator
See what $1,000 in Amgen Inc. would be worth today.
CVS return calculator
See what $1,000 in CVS Health Corporation would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.